These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
329 related articles for article (PubMed ID: 27569350)
21. A hierarchical regulatory network analysis of the vitamin D induced transcriptome reveals novel regulators and complete VDR dependency in monocytes. Warwick T; Schulz MH; Günther S; Gilsbach R; Neme A; Carlberg C; Brandes RP; Seuter S Sci Rep; 2021 Mar; 11(1):6518. PubMed ID: 33753848 [TBL] [Abstract][Full Text] [Related]
22. The vitamin D hormone and its nuclear receptor: molecular actions and disease states. Haussler MR; Haussler CA; Jurutka PW; Thompson PD; Hsieh JC; Remus LS; Selznick SH; Whitfield GK J Endocrinol; 1997 Sep; 154 Suppl():S57-73. PubMed ID: 9379138 [TBL] [Abstract][Full Text] [Related]
23. Thyroid hormone receptor does not heterodimerize with the vitamin D receptor but represses vitamin D receptor-mediated transactivation. Raval-Pandya M; Freedman LP; Li H; Christakos S Mol Endocrinol; 1998 Sep; 12(9):1367-79. PubMed ID: 9731705 [TBL] [Abstract][Full Text] [Related]
24. Genome-wide (over)view on the actions of vitamin D. Carlberg C Front Physiol; 2014; 5():167. PubMed ID: 24808867 [TBL] [Abstract][Full Text] [Related]
25. 1,25-Dihydroxyvitamin D3 up-regulates TLR10 while down-regulating TLR2, 4, and 5 in human monocyte THP-1. Verma R; Jung JH; Kim JY J Steroid Biochem Mol Biol; 2014 May; 141():1-6. PubMed ID: 24373795 [TBL] [Abstract][Full Text] [Related]
26. Lipopolysaccharide negatively modulates vitamin D action by down-regulating expression of vitamin D-induced VDR in human monocytic THP-1 cells. Pramanik R; Asplin JR; Lindeman C; Favus MJ; Bai S; Coe FL Cell Immunol; 2004; 232(1-2):137-43. PubMed ID: 15876428 [TBL] [Abstract][Full Text] [Related]
27. Differential gene regulation by a synthetic vitamin D receptor ligand and active vitamin D in human cells. Iwaki M; Kanemoto Y; Sawada T; Nojiri K; Kurokawa T; Tsutsumi R; Nagasawa K; Kato S PLoS One; 2023; 18(12):e0295288. PubMed ID: 38091304 [TBL] [Abstract][Full Text] [Related]
28. 1,25-Dihydroxyvitamin D3 regulates the expression of low-density lipoprotein receptor-related protein 5 via deoxyribonucleic acid sequence elements located downstream of the start site of transcription. Fretz JA; Zella LA; Kim S; Shevde NK; Pike JW Mol Endocrinol; 2006 Sep; 20(9):2215-30. PubMed ID: 16613987 [TBL] [Abstract][Full Text] [Related]
29. The impact of chromatin organization of vitamin D target genes. Carlberg C; Dunlop TW Anticancer Res; 2006; 26(4A):2637-45. PubMed ID: 16886674 [TBL] [Abstract][Full Text] [Related]
30. Enhanced coactivator binding and transcriptional activation of mutant vitamin D receptors from patients with hereditary 1,25-dihydroxyvitamin D-resistant rickets by phosphorylation and vitamin D analogs. Liu Y; Shen Q; Malloy PJ; Soliman E; Peng X; Kim S; Pike JW; Feldman D; Christakos S J Bone Miner Res; 2005 Sep; 20(9):1680-91. PubMed ID: 16059639 [TBL] [Abstract][Full Text] [Related]
31. Mineralization of three-dimensional osteoblast cultures is enhanced by the interaction of 1α,25-dihydroxyvitamin D3 and BMP2 via two specific vitamin D receptors. Chen J; Dosier CR; Park JH; De S; Guldberg RE; Boyan BD; Schwartz Z J Tissue Eng Regen Med; 2016 Jan; 10(1):40-51. PubMed ID: 23784946 [TBL] [Abstract][Full Text] [Related]
32. 1,25-Dihydroxyvitamin D3 Controls a Cohort of Vitamin D Receptor Target Genes in the Proximal Intestine That Is Enriched for Calcium-regulating Components. Lee SM; Riley EM; Meyer MB; Benkusky NA; Plum LA; DeLuca HF; Pike JW J Biol Chem; 2015 Jul; 290(29):18199-18215. PubMed ID: 26041780 [TBL] [Abstract][Full Text] [Related]
33. Inhibition of 1,25-dihydroxyvitamin D3 stimulated osteocalcin gene transcription by tumor necrosis factor-alpha: structural determinants within the vitamin D response element. Kuno H; Kurian SM; Hendy GN; White J; deLuca HF; Evans CO; Nanes MS Endocrinology; 1994 Jun; 134(6):2524-31. PubMed ID: 8194478 [TBL] [Abstract][Full Text] [Related]
34. Enhancers located in the vitamin D receptor gene mediate transcriptional autoregulation by 1,25-dihydroxyvitamin D3. Zella LA; Kim S; Shevde NK; Pike JW J Steroid Biochem Mol Biol; 2007 Mar; 103(3-5):435-9. PubMed ID: 17218097 [TBL] [Abstract][Full Text] [Related]
35. Primary vitamin D receptor target genes as biomarkers for the vitamin D3 status in the hematopoietic system. Wilfinger J; Seuter S; Tuomainen TP; Virtanen JK; Voutilainen S; Nurmi T; de Mello VD; Uusitupa M; Carlberg C J Nutr Biochem; 2014 Aug; 25(8):875-84. PubMed ID: 24854954 [TBL] [Abstract][Full Text] [Related]
36. Primary Vitamin D Target Genes of Human Monocytes. Nurminen V; Seuter S; Carlberg C Front Physiol; 2019; 10():194. PubMed ID: 30890957 [TBL] [Abstract][Full Text] [Related]
37. Genome-wide effects of chromatin on vitamin D signaling. Hanel A; Malmberg HR; Carlberg C J Mol Endocrinol; 2020 May; 64(4):R45-R56. PubMed ID: 32229699 [TBL] [Abstract][Full Text] [Related]
38. The human transient receptor potential vanilloid type 6 distal promoter contains multiple vitamin D receptor binding sites that mediate activation by 1,25-dihydroxyvitamin D3 in intestinal cells. Meyer MB; Watanuki M; Kim S; Shevde NK; Pike JW Mol Endocrinol; 2006 Jun; 20(6):1447-61. PubMed ID: 16574738 [TBL] [Abstract][Full Text] [Related]
39. An essential role of the CAAT/enhancer binding protein-alpha in the vitamin D-induced expression of the human steroid/bile acid-sulfotransferase (SULT2A1). Song CS; Echchgadda I; Seo YK; Oh T; Kim S; Kim SA; Cho S; Shi L; Chatterjee B Mol Endocrinol; 2006 Apr; 20(4):795-808. PubMed ID: 16357103 [TBL] [Abstract][Full Text] [Related]